Dexamethasone phosphate (4 mg/ml inj): Brand change
The funded brand of dexamethasone phosphate injection - 4 mg per ml - has changed from Max Health to Medsurge.
What changed?
Medsurge was awarded the tender for dexamethasone phosphate injection (4 mg per ml) in August 2025.
Medsurge brand listed from 1 October 2025
The Medsurge brand of dexamethasone phosphate injection (4 mg per ml) was listed from 1 October 2025.
- Chemical: Dexamethasone phosphate
- Presentation: Inj 4 mg per ml, 1 ml ampoule & Inj 4 mg per ml, 2 ml ampoule
- Brand: Dexamethasone Medsurge
- Pharmacode: 2690527, 2690535
- Measure / Qty: per 10
Schedule listing for dexamethasone phosphate(external link)
August 2025 Tender Notification
Max Health brand delisted from 1 March 2026
The Max Health brand of dexamethasone phosphate injection - 4 mg per ml will be delisted from 1 March 2026.
- Chemical: Dexamethasone phosphate
- Presentation: Inj 4 mg per ml, 1 ml ampoule & Inj 4 mg per ml, 2 ml ampoule
- Brand: Hameln
- Pharmacode: 2451689, 2519143
- Measure / Qty: per 10
Schedule listing for dexamethasone phosphate(external link)
August 2025 Tender Notification
Key dates
1 October 2025 | Medsurge brand of dexamethasone phosphate injection - 4 mg per ml listed.
1 March 2026 | Max Health brand of dexamethasone phosphate injection - 4 mg per ml will be delisted.
1 March 2026 | Principal Supply Status (PSS) for Medsurge brand of dexamethasone phosphate injection - 4 mg per ml starts.
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)
Pharmac is a government agency. We do not sell medicines or related products.